Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: An independent test of QUANTEC criteria using a prospectively collected dataset

Vitali Moiseenko, Jonn Wu, Allan Hovan, Ziad Saleh, Aditya Apte, Joseph O. Deasy, Stephen Harrow, Carman Rabuka, Adam Muggli, Anna Thompson

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

Purpose: The severe reduction of salivary function (xerostomia) is a common complication after radiation therapy for head-and-neck cancer. Consequently, guidelines to ensure adequate function based on parotid gland tolerance dose-volume parameters have been suggested by the QUANTEC group and by Ortholan et al. We perform a validation test of these guidelines against a prospectively collected dataset and compared with a previously published dataset. Methods and Materials: Whole-mouth stimulated salivary flow data from 66 head-and-neck cancer patients treated with radiotherapy at the British Columbia Cancer Agency (BCCA) were measured, and treatment planning data were abstracted. Flow measurements were collected from 50 patients at 3 months, and 60 patients at 12-month follow-up. Previously published data from a second institution, Washington University in St. Louis (WUSTL), were used for comparison. A logistic model was used to describe the incidence of Grade 4 xerostomia as a function of the mean dose of the spared parotid gland. The rate of correctly predicting the lack of xerostomia (negative predictive value [NPV]) was computed for both the QUANTEC constraints and Ortholan et al. recommendation to constrain the total volume of both glands receiving more than 40 Gy to less than 33%. Results: Both datasets showed a rate of xerostomia of less than 20% when the mean dose to the least-irradiated parotid gland is kept to less than 20 Gy. Logistic model parameters for the incidence of xerostomia at 12 months after therapy, based on the least-irradiated gland, were D 50 = 32.4 Gy and and γ = 0.97. NPVs for QUANTEC guideline were 94% (BCCA data), and 90% (WUSTL data). For Ortholan et al. guideline NPVs were 85% (BCCA) and 86% (WUSTL). Conclusion: These data confirm that the QUANTEC guideline effectively avoids xerostomia, and this is somewhat more effective than constraints on the volume receiving more than 40 Gy.

Original languageEnglish
Pages (from-to)1108-1114
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume82
Issue number3
DOIs
StatePublished - Mar 1 2012

Keywords

  • Dose-volume effects
  • Head and neck cancer
  • Parotid gland
  • Radiotherapy
  • Xerostomia

Fingerprint

Dive into the research topics of 'Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: An independent test of QUANTEC criteria using a prospectively collected dataset'. Together they form a unique fingerprint.

Cite this